RhumbLine Advisers’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $460K | Buy |
222,438
+50,344
| +29% | +$104K | ﹤0.01% | 2735 |
|
|
2025
Q1 | $379K | Sell |
172,094
-5,587
| -3% | -$12.3K | ﹤0.01% | 2756 |
|
|
2024
Q4 | $272K | Buy |
177,681
+1,895
| +1% | +$2.9K | ﹤0.01% | 3051 |
|
|
2024
Q3 | $350K | Sell |
175,786
-8,686
| -5% | -$17.3K | ﹤0.01% | 2941 |
|
|
2024
Q2 | $646K | Buy |
184,472
+44,230
| +32% | +$155K | ﹤0.01% | 2485 |
|
|
2024
Q1 | $388K | Buy |
140,242
+4,445
| +3% | +$12.3K | ﹤0.01% | 2813 |
|
|
2023
Q4 | $231K | Buy |
135,797
+595
| +0.4% | +$1.01K | ﹤0.01% | 3115 |
|
|
2023
Q3 | $139K | Sell |
135,202
-2,216
| -2% | -$2.28K | ﹤0.01% | 3345 |
|
|
2023
Q2 | $159K | Buy |
137,418
+973
| +0.7% | +$1.13K | ﹤0.01% | 3354 |
|
|
2023
Q1 | $206K | Buy |
136,445
+3,558
| +3% | +$5.37K | ﹤0.01% | 2732 |
|
|
2022
Q4 | $332K | Buy |
132,887
+3,628
| +3% | +$9.06K | ﹤0.01% | 2639 |
|
|
2022
Q3 | $545K | Buy |
129,259
+8,472
| +7% | +$35.7K | ﹤0.01% | 2459 |
|
|
2022
Q2 | $337K | Buy |
120,787
+19,503
| +19% | +$54.4K | ﹤0.01% | 2701 |
|
|
2022
Q1 | $579K | Sell |
101,284
-1,814
| -2% | -$10.4K | ﹤0.01% | 2357 |
|
|
2021
Q4 | $941K | Sell |
103,098
-1,941
| -2% | -$17.7K | ﹤0.01% | 2239 |
|
|
2021
Q3 | $1.12M | Buy |
105,039
+4,210
| +4% | +$45K | ﹤0.01% | 2171 |
|
|
2021
Q2 | $1.57M | Sell |
100,829
-4,047
| -4% | -$62.8K | ﹤0.01% | 2061 |
|
|
2021
Q1 | $1.7M | Sell |
104,876
-10,162
| -9% | -$165K | ﹤0.01% | 1982 |
|
|
2020
Q4 | $2.44M | Buy |
115,038
+176
| +0.2% | +$3.73K | ﹤0.01% | 1756 |
|
|
2020
Q3 | $1.7M | Sell |
114,862
-19,964
| -15% | -$296K | ﹤0.01% | 1765 |
|
|
2020
Q2 | $1.98M | Buy |
134,826
+17,110
| +15% | +$252K | ﹤0.01% | 1732 |
|
|
2020
Q1 | $1.38M | Buy |
117,716
+4,489
| +4% | +$52.7K | ﹤0.01% | 1742 |
|
|
2019
Q4 | $2.66M | Buy |
113,227
+12,425
| +12% | +$292K | ﹤0.01% | 1641 |
|
|
2019
Q3 | $1.87M | Buy |
100,802
+1,124
| +1% | +$20.8K | ﹤0.01% | 1780 |
|
|
2019
Q2 | $1.85M | Buy |
99,678
+11,093
| +13% | +$206K | ﹤0.01% | 1787 |
|
|
2019
Q1 | $2.17M | Sell |
88,585
-956
| -1% | -$23.4K | ﹤0.01% | 1659 |
|
|
2018
Q4 | $2.32M | Buy |
89,541
+30,712
| +52% | +$797K | 0.01% | 1548 |
|
|
2018
Q3 | $1.86M | Sell |
58,829
-572
| -1% | -$18.1K | ﹤0.01% | 1701 |
|
|
2018
Q2 | $2.31M | Buy |
59,401
+10,173
| +21% | +$395K | ﹤0.01% | 1598 |
|
|
2018
Q1 | $1.36M | Buy |
49,228
+6,322
| +15% | +$175K | ﹤0.01% | 1806 |
|
|
2017
Q4 | $777K | Sell |
42,906
-8,214
| -16% | -$149K | ﹤0.01% | 2062 |
|
|
2017
Q3 | $826K | Buy |
51,120
+490
| +1% | +$7.92K | ﹤0.01% | 2068 |
|
|
2017
Q2 | $701K | Buy |
50,630
+6,249
| +14% | +$86.5K | ﹤0.01% | 2145 |
|
|
2017
Q1 | $666K | Buy |
44,381
+9,778
| +28% | +$147K | ﹤0.01% | 2133 |
|
|
2016
Q4 | $453K | Sell |
34,603
-863
| -2% | -$11.3K | ﹤0.01% | 2280 |
|
|
2016
Q3 | $611K | Buy |
35,466
+265
| +0.8% | +$4.57K | ﹤0.01% | 2084 |
|
|
2016
Q2 | $635K | Buy |
35,201
+6,067
| +21% | +$109K | ﹤0.01% | 2044 |
|
|
2016
Q1 | $553K | Buy |
29,134
+80
| +0.3% | +$1.52K | ﹤0.01% | 2159 |
|
|
2015
Q4 | $776K | Buy |
29,054
+2,735
| +10% | +$73K | ﹤0.01% | 1968 |
|
|
2015
Q3 | $642K | Buy |
26,319
+4,734
| +22% | +$115K | ﹤0.01% | 2063 |
|
|
2015
Q2 | $673K | Buy |
21,585
+235
| +1% | +$7.33K | ﹤0.01% | 2136 |
|
|
2015
Q1 | $311K | Buy |
21,350
+4,900
| +30% | +$71.4K | ﹤0.01% | 2589 |
|
|
2014
Q4 | $165K | Buy |
16,450
+575
| +4% | +$5.77K | ﹤0.01% | 2867 |
|
|
2014
Q3 | $132K | Buy |
15,875
+1,925
| +14% | +$16K | ﹤0.01% | 2885 |
|
|
2014
Q2 | $172K | Buy |
+13,950
| New | +$172K | ﹤0.01% | 2887 |
|